One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
Essential medicines for neurological disorders: updates, rejections, and the road ahead
doi : 10.1016/S1474-4422(25)00358-8
Volume 24, Issue 11, November 2025
Treatment of acute central retinal artery occlusion: light at the end of the tunnel?
Predicting stroke risk in women: are inflammation and atherosclerosis enough?
Neuropathology of Alzheimer's disease after anti-amyloid ? antibody treatment
The quality of life of patients with dementia and their caregivers: important and yet inadequately
Wrestling with the consequences of blood tests for Alzheimer's disease
Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial
High-sensitivity C-reactive protein, LDL cholesterol, lipoprotein(a) and 30-year risk of stroke in healthy women: a prospective, longitudinal cohort study
Neuropathological changes and amyloid-related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: a retrospective case–control study
Epidemiology, pathogenesis, and emerging concepts in unruptured intracranial aneurysms
Advances in screening and management of unruptured intracranial aneurysms
The temporal order of genetic, environmental, and pathological risk factors in Parkinson's disease: paving the way to prevention
Environmental toxicants and Parkinson's disease: recent evidence, risks, and prevention opportunities
